Risk for Hepatocellular Carcinoma After Hepatitis C Virus Antiviral Therapy With Direct-Acting Antivirals: Case Closed?

被引：12
|
作者：
Maan, Raoel [1 ]
Feld, Jordan J. [2 ]
机构：
[1] Univ Med Ctr Rotterdam, Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[2] Univ Toronto, Toronto Ctr Liver Dis, Univ Hlth Network, Toronto Gen Hosp, Toronto, ON, Canada
来源：
GASTROENTEROLOGY | 2017年 / 153卷 / 04期
关键词：
SUSTAINED VIROLOGICAL RESPONSE; ALL-CAUSE MORTALITY; REDUCES RISK; LIVER; RECURRENCE; INFECTION; CANCER;
D O I：
10.1053/j.gastro.2017.08.052
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：890 / 892
页数：3
相关论文
共 50 条
  • [41] Risk Factors Contributing to the Occurrence and Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus Patients Treated with Direct-Acting Antivirals
    Kishta, Sara
    Tabll, Ashraf
    Kolaric, Tea Omanovic
    Smolic, Robert
    Smolic, Martina
    BIOMEDICINES, 2020, 8 (06) : 1 - 15
  • [42] Hepatitis C virus relapse after successful treatment with direct-acting antivirals, followed by sarcomatous changes in hepatocellular carcinoma: a case report
    Ken Kurokawa
    Takamasa Ohki
    Jun Kato
    Yukiyo Fukumura
    Makoto Imai
    Chikako Shibata
    Junya Arai
    Mayuko Kondo
    Kaoru Takagi
    Kentaro Kojima
    Michiharu Seki
    Masaya Mori
    Nobuo Toda
    Kazumi Tagawa
    Journal of Medical Case Reports, 14
  • [43] Features of patients who developed hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C Virus
    Mawatari, Seiichi
    Kumagai, Kotaro
    Oda, Kohei
    Tabu, Kazuaki
    Ijuin, Sho
    Fujisaki, Kunio
    Tashima, Shuzo
    Inada, Yukiko
    Uto, Hirofumi
    Saisyoji, Akiko
    Hiramine, Yasunari
    Hashiguchi, Masafumi
    Tamai, Tsutomu
    Hori, Takeshi
    Taniyama, Ohki
    Toyodome, Ai
    Sakae, Haruka
    Kure, Takeshi
    Sakurai, Kazuhiro
    Moriuchi, Akihiro
    Kanmura, Shuji
    Ido, Akio
    PLOS ONE, 2022, 17 (01):
  • [44] Effect of direct-acting antivirals on hepatocellular carcinoma incidence in hepatitis C virus-related cirrhosis
    Navani, V.
    Chan, P.
    Borchard, J.
    Ladera, A.
    Coppock, J.
    Turner, I.
    Shackel, N.
    Levy, M.
    Davison, S.
    Prakoso, E.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 75 - 75
  • [45] Direct-acting antivirals and interferon-based therapy on hepatocellular carcinoma risk in chronic hepatitis-C patients
    Ma, Longteng
    Liu, Jiluo
    Wang, Wei
    Yang, Fan
    Li, Ping
    Cai, Shiliang
    Zhou, Xinyu
    Chen, Xi
    Zhuang, Xun
    Zhang, Hongwei
    Cao, Guangwen
    FUTURE ONCOLOGY, 2020, 16 (11) : 675 - 686
  • [46] EFFECTS OF DIRECT-ACTING ANTIVIRALS FOR HEPATITIS C VIRUS ON HEPATOCELLULAR CARCINOMA AND MORTALITY AMONG MEDICAID BENEFICIARIES
    Song, Hyunjin
    Jiang, Xinyi
    Chang, Ching-Yuan
    Wilson, Debbie
    Lo-Ciganic, Wei-Hsuan
    Park, Haesuk
    GASTROENTEROLOGY, 2022, 162 (07) : S1118 - S1119
  • [47] Con: Treating hepatitis C virus With direct-acting antivirals: Fear not the perceived threat of hepatocellular carcinoma
    Mehta, Neil
    Yao, Francis Y.
    LIVER TRANSPLANTATION, 2017, 23 (12) : 1596 - 1600
  • [48] Multimodal Treatment of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection Treated With Direct-Acting Antivirals
    Mercan-Stanciu, Adriana
    Isac, Teodora
    Rababoc, Razvan
    Rusie, Daniel
    Toma, Letitia
    Vacaroiu, Ileana Adela
    Tulin, Raluca
    Iliescu, Elena Laura
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (05)
  • [49] Predictive Factors of Hepatocellular Carcinoma after Direct-Acting Antivirals Therapy in Chronic Hepatitis C Patients: A Multicenter Study
    Iwata, Tomoaki
    Inoue, Jun
    Akahane, Takehiro
    Kakazu, Eiji
    Ninomiya, Masashi
    Takai, Satoshi
    Nakamura, Takuya
    Sano, Akitoshi
    Masamune, Atsushi
    HEPATOLOGY, 2018, 68 : 352A - 353A
  • [50] Therapy completion of direct-acting antivirals for hepatitis C
    Machado, Marina A. A.
    Moura, Cristiano S.
    Klein, Marina
    Carleton, Bruce
    Winthrop, Kevin
    Abrahamowicz, Michal
    Feld, Jordan
    Curtis, Jeffrey R.
    Bernatsky, Sasha
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 498 - 499
12345